Boehringer Ingelheim and Re-Vana Therapeutics, a U.S. and UK based developer of ocular therapeutics and drug delivery ...

David King of Samsung Biologics shares insights on market demand and the technologies and capabilities needed to support ...

GSK plc has entered into agreements with China-based biotechnology company Hengrui Pharma to develop up to 12 innovative ...

Thomas brings more than 40 years of experience with biological process development and clinical manufacturing.

Eli Lilly and Company has acquired Verve Therapeutics Inc., a Boston-based clinical-stage company developing genetic ...

CS Analytical Laboratory, a cGMP, FDA-registered and inspected contract laboratory designed to serve the regulated testing ...

The Pistoia Alliance is launching two complementary initiatives to transform pharmacovigilance (PV) in response to growing ...

AstraZeneca’s supplemental Biologics License Application (sBLA) for IMFINZI (durvalumab) has been accepted and granted ...

Practical solutions to purification and analytical challenges in PDC manufacturing, along with insights into synthesizing complex peptides, oligonucleotides, and conjugates.

AstraZeneca has announced a $50 billion investment in the United States by 2030, creating tens of thousands of new, highly ...

Tablet lubricants play a key role in pharmaceutical manufacturing, affecting everything from compression behavior to tablet ...

Simtra BioPharma Solutions has purchased a 65-acre property with more than 300,000 square feet of available space for ...